申请人:GPC Biotech AG
公开号:EP2112152A1
公开(公告)日:2009-10-28
The present invention provides derivatives of dihydropteridinone of formula (I). These compounds are inhibitors of Polo-like kinases (Plks), including compounds that show anti-proliferative activity against cells, including against tumor cells, and are useful in the treatment of diseases including cancer.
本发明提供了公式(I)的二氢叶酸酮衍生物。这些化合物是波洛样激酶(Plks)的抑制剂,包括对细胞具有抗增殖活性的化合物,包括对肿瘤细胞的抗活性,并且在治疗包括癌症在内的疾病中是有用的。